Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online:: 40
ORIGINAL ARTICLE
Year : 2010  |  Volume : 13  |  Issue : 1  |  Page : 20-23

Lipid profile in sickle cell disease patients with chronic kidney disease


1 Department of Chemical Pathology, Aminu Kano Teaching Hospital, Kano, Nigeria
2 Department of Medical Laboratory Science, School of Basic Medical, Sciences, University of Benin, Benin City, Nigeria
3 Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria
4 Department of Biochemistry, University of Benin, Benin City, Nigeria

Correspondence Address:
M A Emokpae
Department of Medical Laboratory Science, School of Basic Medical Sciences, University of Benin, Benin City
Nigeria
Login to access the Email id


Rights and Permissions

Background: Dyslipidaemia is reported to occur in patients with sickle cell disease as well as patients with chronic kidney disease irrespective of the haemoglobin genotype. This study aimed at evaluating lipid profile in subjects with sickle cell anaemia (HbSS), sickle cell trait (HbAS) and normal haemoglobin genotype (HbAA), and comparing the lipid parameters between sickle cell disease patients with and those without chronic kidney disease. Methods: A total of 66 patients with chronic kidney disease: 26 HbAA, 24 HbAS and 16 HbSS and 60 apparently healthy controls were recruited for the study. Lipoproteins, urea, creatinine, estimated glomerular filtration rate and electrolytes were determined using standard procedures in both patients and controls. Results: The mean total cholesterol, low density lipoproten cholesterol and high density lipoproten cholesterol in stable HbSS subjects were significantly lower (p<0.001) than those of the HbAS and HbAA controls, while mean triglyceride was significantly higher (p<0.001) in sickle cell disease subjects. The mean total cholesterol in sickle cell disease patients with chronic kidney disease was higher (p<0.001) than sickle cell disease without chronic kidney disease. The potential atherogenic effects of lipids as measured by the artherogenic index were higher in sickle cell disease patients with chronic kidney disease compared with HbAS and HbAA subjects with chronic kidney disease, although lipoprotein changes occurred in all patients with chronic kidney disease irrespective of the haemoglobin genotypes. Conclusion: Dyslipidaemia is present in patients with sickle cell disease and patients with chronic kidney disease irrespective of the haemoglobin genotype. The potential effects of lipids on cardiovascular disease risk as measured by three predictor ratios were higher in HbSS compared to HbAA and HbAS chronic kidney disease patients.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed466    
    Printed16    
    Emailed0    
    PDF Downloaded80    
    Comments [Add]    

Recommend this journal